Literature DB >> 24004554

Alpha thalassemia protects sickle cell anemia patients from macro-albuminuria through its effects on red blood cell rheological properties.

Yann Lamarre1, Marc Romana1, Nathalie Lemonne2, Marie-Dominique Hardy-Dessources1, Vanessa Tarer2, Danielle Mougenel2, Xavier Waltz3, Benoît Tressières4, Marie-Laure Lalanne-Mistrih4, Maryse Etienne-Julan2, Philippe Connes3.   

Abstract

While chronic hemolysis has been suspected to be involved in the development of glomerulopathy in patients with sickle cell anemia (SCA), no study focused on the implications of blood rheology. Ninety-six adults with SCA at steady state were included in the present cross-sectional study. Three categories were defined: normo-albuminuria (NORMO, n = 41), micro-albuminuria (MICRO, n = 23) and macro-albuminuria (MACRO, n = 32). Blood was sampled to measure hematological and hemorheological parameters, and genomic DNA extraction was performed to detect the presence of α-thalassemia. The prevalence of α-thalassemia was lower in the MACRO group compared with the two other groups. Anemia was more severe in the MACRO compared with the NORMO group leading the former group to exhibit decreased blood viscosity. Red blood cell deformability was lower and red blood cell aggregates strength was greater in the MACRO compared to the two other groups, and this was directly attributed to the lower frequency of α-thalassemia in the former group. Our results show the protective role of α-thalassemia against the development of sickle cell glomerulopathy, and strongly suggest that this protection is mediated through the decrease of anemia, the increase of RBC deformability and the lowering of the RBC aggregates strength.

Entities:  

Keywords:  Sickle cell anemia; glomerulopathy; hemolysis; hemorheology

Mesh:

Year:  2014        PMID: 24004554     DOI: 10.3233/CH-131772

Source DB:  PubMed          Journal:  Clin Hemorheol Microcirc        ISSN: 1386-0291            Impact factor:   2.375


  20 in total

1.  Impaired blood rheology plays a role in the chronic disorders associated with sickle cell-hemoglobin C disease.

Authors:  Nathalie Lemonne; Yann Lamarre; Marc Romana; Marie-Dominique Hardy-Dessources; François Lionnet; Xavier Waltz; Vanessa Tarer; Danielle Mougenel; Benot Tressières; Marie-Laure Lalanne-Mistrih; Maryse Etienne-Julan; Philippe Connes
Journal:  Haematologica       Date:  2014-03-14       Impact factor: 9.941

2.  Simvastatin reduces vaso-occlusive pain in sickle cell anaemia: a pilot efficacy trial.

Authors:  Carolyn Hoppe; Eufemia Jacob; Lori Styles; Frans Kuypers; Sandra Larkin; Elliott Vichinsky
Journal:  Br J Haematol       Date:  2017-03-28       Impact factor: 6.998

3.  Influence of alpha thalassemia on clinical and laboratory parameters among nigerian children with sickle cell anemia.

Authors:  Oladele S Olatunya; Dulcineia M Albuquerque; Adekunle Adekile; Fernando F Costa
Journal:  J Clin Lab Anal       Date:  2018-08-20       Impact factor: 2.352

4.  Clinical and genetic predictors of renal dysfunctions in sickle cell anaemia in Cameroon.

Authors:  Amy Geard; Gift D Pule; Bernard Chetcha Chemegni; Valentina J Ngo Bitoungui; Andre P Kengne; Emile R Chimusa; Ambroise Wonkam
Journal:  Br J Haematol       Date:  2017-05-03       Impact factor: 6.998

Review 5.  Emerging point-of-care technologies for sickle cell disease screening and monitoring.

Authors:  Yunus Alapan; Arwa Fraiwan; Erdem Kucukal; M Noman Hasan; Ryan Ung; Myeongseop Kim; Isaac Odame; Jane A Little; Umut A Gurkan
Journal:  Expert Rev Med Devices       Date:  2016-11-22       Impact factor: 3.166

6.  Alpha Globin Gene Copy Number Is Associated with Prevalent Chronic Kidney Disease and Incident End-Stage Kidney Disease among Black Americans.

Authors:  A Parker Ruhl; Neal Jeffries; Yu Yang; Rakhi P Naik; Amit Patki; Lydia H Pecker; Bryan T Mott; Neil A Zakai; Cheryl A Winkler; Jeffrey B Kopp; Leslie A Lange; Marguerite R Irvin; Orlando M Gutierrez; Mary Cushman; Hans C Ackerman
Journal:  J Am Soc Nephrol       Date:  2021-10-27       Impact factor: 10.121

7.  Effects of Senegal haplotype (Xmn1-rs7412844), alpha-thalassemia (3.7kb HBA1/HBA2 deletion), NPRL3-rs11248850 and BCL11A-rs4671393 variants on sickle cell nephropathy.

Authors:  El Hadji Malick Ndour; Khuthala Mnika; Fatou Guèye Tall; Moussa Seck; Indou Dème Ly; Victoria Nembaware; Hélène Ange Thérèse Sagna-Bassène; Rokhaya Dione; Aliou Abdoulaye Ndongo; Jean Pascal Demba Diop; Nènè Oumou Kesso Barry; Moustapha Djité; Rokhaya Ndiaye Diallo; Papa Madièye Guèye; Saliou Diop; Ibrahima Diagne; Aynina Cissé; Ambroise Wonkam; Philomène Lopez Sall
Journal:  Int J Biochem Mol Biol       Date:  2022-04-15

8.  Importance of methodological standardization for the ektacytometric measures of red blood cell deformability in sickle cell anemia.

Authors:  Céline Renoux; Nermi Parrow; Camille Faes; Philippe Joly; Max Hardeman; John Tisdale; Mark Levine; Nathalie Garnier; Yves Bertrand; Kamila Kebaili; Daniela Cuzzubbo; Giovanna Cannas; Cyril Martin; Philippe Connes
Journal:  Clin Hemorheol Microcirc       Date:  2016       Impact factor: 2.375

9.  Sickle cell disease biochip: a functional red blood cell adhesion assay for monitoring sickle cell disease.

Authors:  Yunus Alapan; Ceonne Kim; Anima Adhikari; Kayla E Gray; Evren Gurkan-Cavusoglu; Jane A Little; Umut A Gurkan
Journal:  Transl Res       Date:  2016-03-19       Impact factor: 7.012

10.  Plasma concentration of platelet-derived microparticles is related to painful vaso-occlusive phenotype severity in sickle cell anemia.

Authors:  Danitza Nebor; Andre Bowers; Philippe Connes; Marie-Dominique Hardy-Dessources; Jennifer Knight-Madden; Vanessa Cumming; Marvin Reid; Marc Romana
Journal:  PLoS One       Date:  2014-01-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.